Increased AF1q gene expression in high-risk myelodysplastic syndrome.

Br J Haematol

Clinical Research Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington School of Medicine, Seattle, WA 98109, USA.

Published: January 2005

The AF1q gene is expressed in normal haematopoietic progenitors, but less so in differentiated blood cells. In 47 patients with myelodysplastic syndrome (MDS), AF1q copy numbers were 0-6.8 x 10(6)/microg RNA compared with 1.5-2.4 x 10(5)/microg RNA in normal marrow. AF1q levels correlated with international prognostic scoring system (IPSS) scores (P = 0.004) and the risk of post-transplant relapse (P = 0.05). Among IPSS high-risk patients, survival correlated inversely with AF1q levels (P = 0.04). Thus, AF1q levels correlate with high-risk MDS and may provide a marker for risk stratification.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2004.05306.xDOI Listing

Publication Analysis

Top Keywords

af1q levels
12
af1q gene
8
myelodysplastic syndrome
8
af1q
5
increased af1q
4
gene expression
4
expression high-risk
4
high-risk myelodysplastic
4
syndrome af1q
4
gene expressed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!